French lawmakers are voting today on a law regarding end-of-life care and medical aid in dying [1].

The legislation represents a key promise of President Emmanuel Macron's second five-year term. It seeks to establish a legal framework for medical assistance in dying after years of legislative deadlock [2, 3].

Government spokesperson Maud Bregeon said the bill during an interview at the BFMTV-RMC studios in Paris [1]. The vote scheduled for July 15 follows a period of intense legislative scrutiny [1]. The text previously passed its first reading on June 30 [2].

Legislators have navigated a complex process to reach this stage. During the debates, the National Assembly examined 1,800 amendments to the text [3]. This high volume of changes reflects the deep ethical and legal divisions surrounding the issue of assisted dying in France.

While the primary focus of the day remains the end-of-life bill, Bregeon also addressed other pressing national issues during her media appearances. She mentioned the use of the "Fonds vert," or Green Fund, to address environmental and infrastructure needs.

"I am in favor of the Green Fund also being able to finance air conditioning where it is necessary," Bregeon said [4].

The final vote in the National Assembly will determine if the framework for medical aid in dying becomes law, marking a significant shift in French healthcare policy and bioethics [1, 2].

“The legislation represents a key promise of President Emmanuel Macron's second five-year term.”

The vote on the end-of-life bill signals a potential pivot in French law toward permitting medical aid in dying, a move that has been blocked for four years. By attempting to codify these practices, the Macron administration is seeking to resolve a long-standing tension between patient autonomy and the traditional medical ethics of the French state.